Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F9G51
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,478
Award facts
- Contract value 100% obligated
- $57,477.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,477.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units, with an ultimate completion date of November 19, 2025. This non-set-aside contract represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, a major healthcare solutions provider that serves critical federal medical procurement needs across military and veteran healthcare systems. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen's comprehensive IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The company's established relationship with the Defense Logistics Agency and track record of delivering diverse pharmaceutical products through firm fixed-price arrangements demonstrate its capability to meet federal medical supply requirements. This delivery order for DESCOVY, an HIV treatment medication, reflects the broader scope of pharmaceutical support that AmerisourceBergen provides to the Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to support military readiness.
Quick answers
Who was awarded contract SPE2DR26F9G51?
SPE2DR26F9G51 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F9G51 worth?
The government has obligated $57,478 on SPE2DR26F9G51.
Is contract SPE2DR26F9G51 an order under another contract?
Yes. SPE2DR26F9G51 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9G51 competed?
The extent of competition for SPE2DR26F9G51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award